Cancer patients get lifeline: continued access to treatment after trial ends
NCT ID NCT05160922
Summary
This study provides continued access to crizotinib treatment for people with certain cancers who were already benefiting from the medication in previous Pfizer trials that are closing. It allows 27 eligible participants to keep receiving their treatment while researchers continue monitoring safety. The main goal is to track side effects and ensure continued access to a medication that's helping control their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Monza
Monza, MB, 20900, Italy
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Cancer Hospital Chinese Academy of Medical Science
Beijing, Beijing Municipality, 100021, China
-
Fujian Province Oncology Hospital
Fuzhou, Fujian, 350014, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130028, China
-
Limited Liability Company "EuroCityClinic"
Saint Petersburg, 197022, Russia
-
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001, Japan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Shanghai Chest Hospital
Shanghai, 200030, China
-
Sun Yat-Sen University Cancer center
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of College of Medicine,Zhejiang University
Hangzhou, Zhejiang, 310003, China
-
The First Affiliated Hospital of Guangzhou Medical University.
Guangzhou, 510120, China
-
West China Hospital of Sichuan University
Wuhou District, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.